Location: Home
  • search
  • go
  • Relate News
  • 2/7/2012Latest executive and official moves
  • 2/6/2012Biospectrum: Asia Bullish on Biologics Manufacturing
  • 2/3/2012Nanjing Pharma reports loss for 2011, making it an ideal target for ac...
  • 2/3/2012Innovating in China's Pharma Market: McKinsey's Interview with Steve Y...
  • 2/3/2012Bloomburg: Wuxi PharmaTech and ShangPharma ripe for takeover by global...
  • 2/3/2012Big pharma companies join hands to fight neglected tropical diseases
  • 2/3/2012MOH issues its key health tasks in 2012
  • 2/1/2012SFDA terminates administrative protection of two Roche products
  • 1/31/2012Recent executive moves
  • 1/27/2012Global pharma deal-making fell 18% in 2011
  • 1/27/2012New study: drug companies expand use of strategic partnerships
  • 1/26/2012Major drug regulations and laws currently under drafting process in 20...
  • 1/24/2012Recent executive moves
  • 1/23/2012IMS Health: China Pharmaceutical Market Snapshot in Q3/2011
  • 1/20/2012New report: antithrombotic drug market will rise to 24.4B in 2015
  • 1/20/2012Dishman close to a deal selling its brand new Chinese API plant
  • 1/20/2012Sinochem, DSM forms strategic alliance for biotech business
  • 1/19/2012MIIT issues the 12th FYP for the Chinese pharmaceutical industry
  • 1/19/2012Recent official and executive moves
  • 1/18/2012Novartis gains Chinese approval for Lucentis as it launches Galvus
  • 1/18/2012Takeda structures to integrate acquired Nycomed
  • 1/17/2012Pharma M&As rebouned in 2011 with surging BRIC deals
  • 1/17/2012Updated: RDPAC member companies set up more R&D centers in China
  • 1/12/2012SinoPharm Group's revenues exceeded CNY 110 billion in 2011
  • 1/12/2012Hengrui enters strategic partnership with Crown Bioscience for a novel...
  • 1/12/2012SMEI ranks top ten Chinese pharma companies in 2011 by four criterions
  • 1/12/2012Amerigen enters agreement with Fosun Omni for co-development of contro...
  • 1/12/2012Amerigen and VIWA Pharma forms branded generic JV for China
  • 1/11/2012Chinese pharma growth expected to slow mildly in 2012
  • 1/11/2012McKinsey: The good days of the pharma industry are gone forever
  • Page:288/362 Total number of articles:10841: [First][<<] [286] [287] [288] [289] [290] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group